Monday, August 14, 2017 1:32:33 PM
1) The FDA determined that an interim report is not needed since the DSMC will review the data up to the end of August. My read is that the last DSMC data was positive enough that the FDA is comfortable with waiting for the DSMC report in September.
2) There are some patients that are being treated for a long time. Dror is blinded but his assumption is that avastin data will reflect historic results and thus, these patients are most likely being treated with VB-111.
3) Some other positive flags. New facilities are on schedule to support production. BLA being discussed.
I'm cautiously optimistic. No worries based on my due diligence.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM